Ardelyx (ARDX) Operating Margin Growth (3y) (2018 - 2026)
Ardelyx (ARDX) Operating Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ardelyx |
1.49 Bn |
1.25 Bn |
89.66 Mn |
19,454.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
19,454.00 |
| Dec 31, 2025 |
-2,341.00 |
| Sep 30, 2025 |
57,612.00 |
| Jun 30, 2025 |
102,307.00 |
| Mar 31, 2025 |
589,262.00 |
| Dec 31, 2024 |
343,489.00 |
| Sep 30, 2024 |
360,295.00 |
| Jun 30, 2024 |
339,586.00 |
| Mar 31, 2024 |
43,263.00 |
| Dec 31, 2023 |
144,664.00 |
| Sep 30, 2023 |
64,567.00 |
| Jun 30, 2023 |
124,403.00 |
| Mar 31, 2023 |
156,539.00 |
| Dec 31, 2022 |
86,518.00 |
| Sep 30, 2022 |
29,429.00 |
| Jun 30, 2022 |
13.69 Mn |
| Dec 31, 2021 |
2.88 Mn |
| Sep 30, 2021 |
1.02 Mn |
| Jun 30, 2021 |
7.04 Mn |
| Mar 31, 2021 |
27,603.00 |
